These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6871886)

  • 1. Conservative management without alkylating agents of squamous cell anal cancer using cyclical 5-FU alone and x-ray therapy.
    Byfield JE; Barone RM; Sharp TR; Frankel SS
    Cancer Treat Rep; 1983; 67(7-8):709-12. PubMed ID: 6871886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined radical radiation therapy and chemotherapy for primary squamous cell carcinoma of the anal canal.
    Cummings BJ; Rider WD; Harwood AR; Keane TJ; Thomas GM; Erlichman C; Fine S
    Cancer Treat Rep; 1982 Mar; 66(3):489-92. PubMed ID: 6800654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome.
    Roohipour R; Patil S; Goodman KA; Minsky BD; Wong WD; Guillem JG; Paty PB; Weiser MR; Neuman HB; Shia J; Schrag D; Temple LK
    Dis Colon Rectum; 2008 Feb; 51(2):147-53. PubMed ID: 18180997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
    Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
    Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative treatment for carcinoma of the anus--a report of 35 patients.
    Serkies K; Bednaruk-Mlynski E; Dziadziuszko R; Jassem J
    Neoplasma; 2003; 50(2):152-8. PubMed ID: 12740652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of patients with squamous cell carcinoma of the anal canal in the last 20 years in a gastroenterology hospital].
    Hwang HJ; Bestani C; Jiménez R; Masciángioli G; Gutiérrez A; Cartelli C; Rafailovici L; Barugel M; Rodríguez G; Méndez G
    Acta Gastroenterol Latinoam; 2005; 35(2):94-8. PubMed ID: 16127985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.
    John M; Pajak T; Flam M; Hoffman J; Markoe A; Wolkov H; Paris K
    Cancer J Sci Am; 1996; 2(4):205-11. PubMed ID: 9166533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy.
    Blazy A; Hennequin C; Gornet JM; Furco A; Gérard L; Lémann M; Maylin C
    Dis Colon Rectum; 2005 Jun; 48(6):1176-81. PubMed ID: 15906137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Squamous cell carcinoma of the canal anal].
    Guimarães AP; Matos D; Segreto R; Forones NM
    Arq Gastroenterol; 2001; 38(1):9-13. PubMed ID: 11582966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.
    Wexler A; Berson AM; Goldstone SE; Waltzman R; Penzer J; Maisonet OG; McDermott B; Rescigno J
    Dis Colon Rectum; 2008 Jan; 51(1):73-81. PubMed ID: 18066626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.
    Edelman S; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):206-11. PubMed ID: 16904522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
    Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management of epidermoid carcinoma of the anal canal.
    Cummings BJ
    Gastroenterol Clin North Am; 1987 Mar; 16(1):125-42. PubMed ID: 3298050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two cases of squamous cell carcinoma of the anal canal treated with chemoradiotherapy].
    Sasaoka M; Fuwa N; Matsumoto A; Furutani K; Kamata M; Kodaira T
    Gan To Kagaku Ryoho; 2001 Mar; 28(3):399-402. PubMed ID: 11265413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
    Salama JK; Mell LK; Schomas DA; Miller RC; Devisetty K; Jani AB; Mundt AJ; Roeske JC; Liauw SL; Chmura SJ
    J Clin Oncol; 2007 Oct; 25(29):4581-6. PubMed ID: 17925552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
    Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ
    Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.